Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ERBB-3 (HER3) is a receptor tyrosine kinase belonging to the ErbB family. While it has impaired kinase activity, it plays a crucial role in cell signaling, particularly through heterodimerization with other ErbB receptors like HER2, leading to activation of the PI3K/Akt pathway. HER3 is implicated in cancer development, progression, and resistance to therapies targeting other ErbB family members.
Inhibition of HER3 signaling, disruption of HER3 dimerization, targeting downstream effectors (e.g., PI3K/Akt)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ERBB-3 receptor (HER3).